Impact Factor
3.06
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.04
292 total citations
h5-index
21
h5 depth signal
Cited share
68.8%
108 of 157
Total citations
292
Citation footprint
Metric signal
2.00
External metric anchor
Self-citation
5.8%
17 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
386
United Kingdom
75
Canada
68
China
47
Japan
43
Citing Fields of Research
Reproductive Health
691
Oncology
409
Obstetrics/Gynecology
179
Musculoskeletal & Nerve Cancer
137
Testicular Disorders
94
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,491
Articles tracked across the journal lifetime
Indexed publication set
157
108 cited publications
Last 12 months
81
6.8 publications/month
Open access share
11.1%
9 OA publications in the last year
Leading citing country
United States
386 citing publications
Leading citing field
Reproductive Health
691 citing publications
Latest tracked publication
12 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1982-
v1n1, 1982-
Active Coverage
Research Focus & Classification
Indexed Subjects
Reproductive Health
Oncology
Musculoskeletal & Nerve Cancer
Issuing & Sponsoring Bodies
Contributor
International Society of Gynecological Pathologists
Broad Categories
Gynecology
Pathology
Reproductive Health
MeSH Descriptors
Gynecology
Pathology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1097/pgp.0000000000001221
Open DOI
Vulvovaginal Myxoid Epithelioid Smooth Muscle Tumor With NCOA2 Rearrangement: Case Report and Literature Review
Vulvovaginal myxoid epithelioid smooth muscle tumor with NCOA2 rearrangement is an emerging, rare mesenchymal neoplasm of the female genital tract. We reported a 56-yr-old Chinese woman with a slow-growing, tender mass in the right labiu...
02
DOI 10.1097/pgp.0000000000001219
Open DOI
Repurposing Gastric Cancer Biomarkers for Mucinous Ovarian Carcinoma: ERBB2 and Claudin 18.2 as Therapeutic Targets
Mucinous ovarian carcinomas (MOCs) have an upper-gastrointestinal cell phenotype (CK7+/SATB2−) similar to pancreatic ductal adenocarcinoma (PDAC) and gastric adenocarcinoma (GA). We aimed to develop an immunohistochemical panel that accu...
03
DOI 10.1097/pgp.0000000000001218
Open DOI
Interobserver Variability in Diagnosing STIC With Frequent Underdiagnosis of Early High-grade Serous Carcinoma: Insights From a Multicenter Review From the CANSTIC Study
It has become widely accepted that most cases of tubo-ovarian high-grade serous carcinoma (HGSC) arise from precursor lesions in the fallopian tube called serous tubal intraepithelial carcinoma (STIC). This study evaluated the interobser...
04
DOI 10.1097/pgp.0000000000001206
Open DOI
Primary Vulvar HPV-independent Adenosquamous Carcinoma: A Case Series of a Rare Neoplasm With an Apparent Predilection for the Upper Vulva
Adenosquamous carcinoma is a rare malignancy described in a variety of body sites, including the uterine cervix. These tumors exhibit morphologically unequivocal areas of squamous and glandular differentiation and are typically associate...
05
DOI 10.1097/pgp.0000000000001217
Open DOI
Diagnostically Confusing Aspects of the Physiologic Ovarian Follicle: A Report of 57 Cases and Brief Review of Selected Other Non-neoplastic Ovarian Lesions
We performed a retrospective review of cases sent in consultation wherein physiological ovarian follicles, corpora lutea, or their constituent cells raised concern for malignancy based on architectural or cytologic features. The 57 cases...
06
DOI 10.1097/pgp.0000000000001216
Open DOI
Unusual Variants of Endometrial Stromal Sarcoma
Endometrial stromal sarcoma (ESS) is traditionally classified into low-grade (LGESS) and high-grade (HGESS) categories based on morphology, immunophenotype, and specific molecular alterations. Some tumors, however, defy these patterns, d...
07
DOI 10.1097/pgp.0000000000001215
Open DOI
Poor Prognosis and High Recurrence in NTRK3 Fusion Cervical Sarcoma: A Series of 3 Cases and Literature Review
This study aimed to expand the morphologic and molecular spectrum of NTRK -rearranged uterine tumors by reporting 3 cases of NTRK3 -fusion cervical sarcoma and conducting a literature review, thereby strengthening the understanding of th...
08
DOI 10.1097/pgp.0000000000001214
Open DOI
Uterine Carcinosarcoma: Mutational Profiling of p53-Abnormal Tumors and Its Association with Histologic Subtypes and Survival in an Underserved Population
Uterine carcinosarcoma is a rare and highly aggressive malignancy characterized by biphasic epithelial and mesenchymal components. Although molecular classification has improved risk stratification in endometrial carcinoma, the mutationa...
09
DOI 10.1097/pgp.0000000000001211
Open DOI
POLD1 and Endometrial Cancer: Molecular Mechanisms, Genomic Pathology, and Emerging Therapeutics
Endometrial cancer (EC) is a major gynecologic malignancy whose classification and treatment paradigms are evolving because of molecular profiling. Mutations in DNA polymerases, particularly in DNA polymerase epsilon ( POLE ) and DNA pol...
10
DOI 10.1097/pgp.0000000000001212
Open DOI
Novel Gene Fusions and Pathogenic CTNNB1 Mutation in Pilomatrix-like High-grade Endometrioid Carcinoma: Expanding the Molecular Spectrum
Was not provided for this article.
Bibliographical & Catalog Notes
Title from cover.
Place of publication varies.
Also issued online.
Vol. 4, no. 1 (1985)19900914 Notice not published Printed on acid-free paper